|Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay--a comparative study.|
|Jump to Full Text|
|PMID: 22214341 Owner: NLM Status: MEDLINE|
|For studying proliferation and determination of survival of cancer cells after irradiation, the multiple MTT assay, based on the reduction of a yellow water soluble tetrazolium salt to a purple water insoluble formazan dye by living cells was modified from a single-point towards a proliferation assay. This assay can be performed with a large number of samples in short time using multi-well-plates, assays can be performed semi-automatically with a microplate reader. Survival, the calculated parameter in this assay, is determined mathematically. Exponential growth in both control and irradiated groups was proven as the underlying basis of the applicability of the multiple MTT assay. The equivalence to a clonogenic survival assay with its disadvantages such as time consumption was proven in two setups including plating of cells before and after irradiation. Three cell lines (A 549, LN 229 and F 98) were included in the experiment to study its principal and general applicability.|
|Karl Buch; Tanja Peters; Thomas Nawroth; Markus Sänger; Heinz Schmidberger; Peter Langguth|
|Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't Date: 2012-01-03|
|Title: Radiation oncology (London, England) Volume: 7 ISSN: 1748-717X ISO Abbreviation: Radiat Oncol Publication Date: 2012|
|Created Date: 2012-02-08 Completed Date: 2012-06-01 Revised Date: 2013-06-26|
Medline Journal Info:
|Nlm Unique ID: 101265111 Medline TA: Radiat Oncol Country: England|
|Languages: eng Pagination: 1 Citation Subset: IM|
|Department of Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg-University, Staudingerweg 5, 55099 Mainz, Germany.|
|APA/MLA Format Download EndNote Download BibTex|
Carcinoma, Non-Small-Cell Lung
Cell Proliferation / radiation effects*
Cell Survival / radiation effects
Glioblastoma / drug therapy, pathology*
Lung Neoplasms / drug therapy, pathology*
Tumor Cells, Cultured
Tumor Stem Cell Assay*
Journal ID (nlm-ta): Radiat Oncol
Publisher: BioMed Central
Copyright ©2012 Buch et al; licensee BioMed Central Ltd.
Received Day: 6 Month: 12 Year: 2011
Accepted Day: 3 Month: 1 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 3 Month: 1 Year: 2012
Volume: 7First Page: 1 Last Page: 1
Publisher Id: 1748-717X-7-1
PubMed Id: 22214341
|Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay - A comparative study|
|Karl Buch1||Email: email@example.com|
|Tanja Peters1||Email: firstname.lastname@example.org|
|Thomas Nawroth1||Email: email@example.com|
|Markus Sänger2||Email: firstname.lastname@example.org|
|Heinz Schmidberger2||Email: email@example.com|
|Peter Langguth1||Email: firstname.lastname@example.org|
1Department of Pharmaceutical Technology and Biopharmaceutics, Johannes Gutenberg-University, Staudingerweg 5, 55099 Mainz, Germany
2Department of Radiooncology and Radiotherapy, University Medical Center, Johannes Gutenberg-University, Langenbeckstrasse 1, 55131 Mainz, Germany
Clonogenic and MTT assays are well-known tests for evaluation of chemoradiation studies and radiosensitivity [1-4]. Clonogenic assays are commonly used to investigate survival of irradiated cancer cells, whereas MTT assays are well known to study chemosensitivity  or toxicity  of drugs in human tumor cell lines. The assay is less common to study survival of cancer cells after irradiation, in particular when the MTT assay is performed for studying proliferation of treated cells.
The aim of this study is to compare the well-established clonogenic assay with an adapted version of the MTT proliferation assay to overcome limitations such as long duration of experiment, low sample throughput, limited error level and time-consuming counting of clones.
The MTT assay is based on the formation of dark-colored formazan dye by reduction of the tetrazolium salt MTT by metabolically active cells . After some incubation, the water-insoluble formazan dye forms crystals, which can be dissolved in an organic solvent and the amount can be determined semi-automatically using a microplate reader. Absorbance readings are related to the number of cells  therefore providing the possibility to use the MTT assay as a proliferation assay to assess cell growth after irradiation. In the present study our adapted version of the MTT assay is compared to the clonogenic assay in order to open the possibility of replacing one by the other.
In the literature, several studies on comparability of MTT and clonogenic assay can be found. There, the MTT assay is done as a single-point assay after a defined time following treatment. In this case, much information about the growth behavior of the cells is lost (doubling time, lag phase, growth behavior etc.). In contrast, with our multiple MTT assay, we collect all those data and use them for more detailed interpretation.
Experiments were carried out with A 549 cells (human NSCLC cell line), LN 229 cells (human glioblastoma cell line) and F 98 cells (glioblastoma cell line from rats). Cells were purchased from DSMZ (Braunschweig, Germany) and from ATCC (Manassas, USA). Cells were cultured in DMEM, supplemented with 10% fetal bovine serum (FBS), 10 mg/ml antibiotics (penicillin and streptomycin) at 37°C with 5% CO2 in humidified air. Cell media were obtained from Invitrogen (Darmstadt, Germany). All other chemicals were purchased from Roth (Karlsruhe, Germany). Cell concentrations in the culture were adjusted to allow for exponential growth.
The irradiation cell culture experiment was based on literature methods . Two essentially different ways of performing this study can be carried out: Plating of cells before or after irradiation. Plating before irradiation is often used as a screening method of sensitivity and efficiency of different treatments. Plating after treatment is used especially to investigate cell damage repair . Both methods were integrated in this study.
For irradiation experiments, cells were grown in flasks (25 cm2) to reach 90% confluence and they were completely filled with DMEM to avoid artifacts by irradiation through air layers. Treated cells were harvested the next day using trypsinization, counted and a specific number of cells (500 and 250 cells) was plated in petri dishes in triplicate for clonogenic assay. The multiple MTT assay was performed using 96-well-plates with 4,000 and 2,000 cells (for A 549) per well, respectively. Plating density for LN 229 was adapted to the size of the cells.
Cells from a stock culture were plated following appropriate dilutions (100 and 50 cells/well for A 549, adapted to the smaller size of a well compared to a petri dish) into 6-well-plates as well as into 96-well-plates (4,000 and 2,000 cells/well for A 549) for multiple MTT assay and allowed to attach overnight. Irradiation treatment was performed on the next day. Plating density for LN 229 and F 98 was adapted to the size of the cells.
Dishes and multi-well-plates were placed in an incubator. Dishes and 6-well-plates were left there for 9 days until large clones (> 1 mm) were formed (50 cells or more). Staining of colonies was done as described below.
Commonly, plating densities for clonogenic assays were adapted paying attention to the situation that the endpoint analysis of this assay is determined optically by counting clones. Therefore, plating density must not be too high or clones will coalesce and counting of single colonies will become impossible. This fact does not play a role in our multiple MTT assay where analysis is done photometrically. Here, the only limitation to the validity of the results of the MTT assay is, when confluence has been reached or in cases where cell growth has stopped due to depletion of medium. Previous experiments showed that plating densities can vary from 500 cells/well up to 20,000 cells/well (data not shown here).
Irradiation was done using a 6 MV linear accelerator Siemens MD-2 using a clinically calibrated irradiation field of 20 × 20 cm. The irradiation dose varied between 0 and 15 Gy. For plating after irradiation, cell culture flasks were completely filled with medium and irradiated horizontally in upright position with RW3-plastic material in front of the flasks and behind as phantom simulating tissue. For plating before irradiation, the plates were placed horizontally and covered with RW3-plates as well.
Medium was removed in both dishes and plates, cells were rinsed with PBS. Fixation and staining of clones was done with a mixture of 0.5% crystal violet in 50/50 methanol/water for 30 min. Dishes were rinsed with water and left for drying at room temperature. Counting of clones was done on the following day.
The protocol is adapted from literature methods . Briefly, DMEM was supplemented with 100 μl of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) reagent (c = 0.5 g/l) to each well and incubated for 30 min at 37°C. Thereafter MTT solution was removed. After addition of 180 μl of DMSO the plates were incubated for 15 min at 37°C to dissolve the formazan crystals. Absorbance readings of DMSO extracts were performed at 560 nm with reference of 690 nm using a Tecan Infinite F 200 microplate reader (Crailsheim, Germany).
After counting clones, plating efficiency (PE) and survival fraction (SF) can be calculated using the following equations :
PE was about 64% for both methods (plating before and after irradiation) of this study. SF data of all investigated cell lines are shown in Table 1. The survival curves which have been obtained using different plating densities were virtually identical and therefore were averaged.
MTT assay was done once every day with one column of each multi-well-plate to follow up exponential growth of cells. MTT readings are proportional to the number of cells in-vitro, at least in the phase of exponential growth. This fact is described in the literature  and was verified in our lab (data not shown). For calculation of the proliferation survival, only the early exponential phase of cell growth is used in the following equation (a derived equation, developed by ourselves):
tdoubling time = the time period required for a quantity of cells to double
tdelay = the time period to reach specific absorption value of control vs. irradiated cells (graphically shown in Figure 1)
Survival results are shown in Table 2.
In Figure 2a and 2b the survival data for A 549 cells of clonogenic and multiple MTT assay are plotted against irradiation dose. The correlation of both assays is presented in Figure 2c and 2d (R2 = 0.99 for both). As expected, the survival curves of both assays show the same characteristics: the survival depends on the dose of irradiation and an increase of dose leads to a decrease in survival, approaching zero in case of plating the cells after irradiation. Clonogenic and multiple MTT assay show very similar curve progression, while the multiple MTT assay gives slightly higher activity results. This fact may be explained by the presence of cells which are alive and show metabolic activity, but poor or no cell proliferation. Those cells gain more influence in the outcome of survival in case of the multiple MTT assay. If the plating of cells is done before irradiation, metabolic cell activity during the following assay may vary significantly. Cells with low metabolic activity and slow proliferation or cells which ceased to proliferate, are excluded from the assay by washing and trypsinization, when the plating is done after irradiation. However, as shown in Figure 2d, the correlation between clonogenic and multiple MTT assay is still very good and linear.
To prove general applicability of our method, further cell lines were included in this study. Survival data for LN 229 cells of clonogenic and multiple MTT assay are shown in Figure 3a and 3b as a plot of survival against irradiation dose. The correlation of the two assays is shown in Figure 3c and 3d (R2 = 0.96 and R2 = 0.72, respectively). Curve progression of clonogenic survival is similar to MTT survival, while clonogenic survival decreased even more than MTT survival. Correlation of the two assays is still acceptable for plating after irradiation (R2 = 0.96), for plating before irradiation the correlation quality decreased (R2 = 0.72).
For the setup 'plating before irradiation' A 549 cells showed a very good correlation, LN 229 reduced correlation quality. Therefore, we included a third cell line (F 98) in this study to prove the general applicability. Survival data are shown in Figure 4b, correlation data are shown in Figure 4d (R2 = 0.98) as a good linearity between the two assays.
The biggest advantage of performing the multiple MTT assay is that, due to the fact that our assay is not only a single-point determination of survival, information about growth performance can be acquired easily. Degrees of direct cell death, lag phase after irradiation and changes in doubling-time can be measured by assay-time-points before and after irradiation. Even if growth becomes exponential again after the lag phase due to irradiation treatment, doubling-time maybe not the same as in control  in our study but increases following irradiation with high doses.
Our results suggest that the multiple MTT assay can be a surrogate of the clonogenic assay in order to determine survival of irradiated tumor cells. Requirements for correct interpretation of results are on the one hand linearity of cell number and MTT reading and on the other hand, a sufficient number of time points over several cell generations in order to predict growth behavior accurately. The main and only disadvantage of this assay is that the survival may be overestimated at high radiation doses in the case of plating before irradiation. However, correlation of multiple MTT and clonogenic assay is good and trends can be determined anyway; an important fact when different treatments under equal irradiation doses are performed. The main advantage of the multiple MTT assay presented is the opportunity to obtain precise survival data for high sample throughput in less time and with less effort than with the conventional colony assay.
In order to establish the multiple MTT assay instead of a clonogenic assay it is expedient to examine the transferability of the method first. An experimental setup reduced to two or three radiation doses should be sufficient to verify the comparability.
The authors declare that they have no competing interests.
KB and TP designed the experimental setup and carried out the cell culture experiments. MS calculated the irradiation parameters and operated the linear accelerator, TN developed the multiple MTT assay model, HS allocated the irradiation facility, HS and PL conceived of the study, KB drafted the manuscript. All authors read and approved the final manuscript.
Financial support by the Bundesministerium für Bildung und Forschung (05KS7UMA) is greatfully acknowledged.
|Pauwels B,Korst AE,de Pooter CM,Pattyn GG,Lambrechts HA,Baay MF,Lardon F,Vermorken JB,Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studiesCancer Chemother PharmacolYear: 20035122122612655440|
|Saunders MI,Predictive testing of radiosensitivity in non-small cell carcinoma of the lungLung CancerYear: 199410Suppl 1S83908087531|
|Williams JR,Zhang Y,Zhou H,Gridley DS,Koch CJ,Slater JM,Little JB,Overview of radiosensitivity of human tumor cells to low-dose-rate irradiationInt J Radiat Oncol Biol PhysYear: 20087290991710.1016/j.ijrobp.2008.06.192819014780|
|Eble MJ,Hensley FW,Flentje M,Schlotz A,Wannenmacher M,A modified computer-assisted colorimetric microtitre assay (MTT) to assess in vitro radiosensitivity of V79, CaSki, HeLa and WiDr cellsInt J Radiat BiolYear: 19946519320110.1080/095530094145502317907117|
|Kratzke RA,Kramer BS,Evaluation of in vitro chemosensitivity using human lung cancer cell linesJ Cell Biochem SupplYear: 1996241601648806098|
|Foldbjerg R,Dang DA,Autrup H,Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549Arch ToxicolYear: 2010|
|Hansen J,Bross P,A cellular viability assay to monitor drug toxicityMethods Mol BiolYear: 201064830331110.1007/978-1-60761-756-3_2120700722|
|Price P,McMillan TJ,Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiationCancer ResYear: 199050139213962302704|
|Franken NA,Rodermond HM,Stap J,Haveman J,van Bree C,Clonogenic assay of cells in vitroNat ProtocYear: 200612315231910.1038/nprot.2006.33917406473|
|Price P,McMillan TJ,The use of non-clonogenic assays in measuring the response of cells in vitro to ionising radiationEur J CancerYear: 199430A8388417917545|
Clonogenic Assay: Surviving Fraction (SF) of irradiated cells (n = 3 for each experiment); n.d. = not determined
|plating after irradiation||plating before irradiation|
|A 549||250 cells||500 cells||mean value||S.D.||50 cells||100 cells||mean value||S.D.|
|LN 229||250 cells||500 cells||Mean value||S.D.||100 cells||200 cells||Mean value||S.D.|
|F 98||75 cells||100 cells||Mean value||S.D.|
Multiple MTT assay: Survival of irradiated cells (n = 8 for each experiment); n.d. = not determined
|plating after irradiation||plating before irradiation|
|A 549||2000 cells||4000 cells||mean value||S.D.||2000 cells||4000 cells||mean value||S.D.|
|1 Gy||64.3%||63.0%||63.7%||0.9%||102.6 &||87.5%||95.0%||10.7%|
|LN 229||2500 cells||4000 cells||Mean value||S.D.||2500 cells||5000 cells||Mean value||S.D.|
|F 98||2500 cells||4000 cells||Mean value||S.D.|
Previous Document: Very high thermopower of Bi nanowires with embedded quantum point contacts.
Next Document: Association of polymorphisms in survivin gene with the risk of hepatocellular carcinoma in Chinese h...